These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 15207276
1. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Tomás-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL. Neurobiol Dis; 2004 Jun; 16(1):190-201. PubMed ID: 15207276 [Abstract] [Full Text] [Related]
2. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection. Ruano D, Revilla E, Gavilán MP, Vizuete ML, Pintado C, Vitorica J, Castaño A. Neuroscience; 2006 Jul 21; 140(4):1157-68. PubMed ID: 16713109 [Abstract] [Full Text] [Related]
3. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. Villarán RF, Espinosa-Oliva AM, Sarmiento M, De Pablos RM, Argüelles S, Delgado-Cortés MJ, Sobrino V, Van Rooijen N, Venero JL, Herrera AJ, Cano J, Machado A. J Neurochem; 2010 Sep 21; 114(6):1687-700. PubMed ID: 20584104 [Abstract] [Full Text] [Related]
4. Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Hernández-Romero MC, Delgado-Cortés MJ, Sarmiento M, de Pablos RM, Espinosa-Oliva AM, Argüelles S, Bández MJ, Villarán RF, Mauriño R, Santiago M, Venero JL, Herrera AJ, Cano J, Machado A. Neurotoxicology; 2012 Jun 21; 33(3):347-60. PubMed ID: 22330755 [Abstract] [Full Text] [Related]
5. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P. Eur J Neurosci; 2005 Jul 21; 22(2):317-30. PubMed ID: 16045485 [Abstract] [Full Text] [Related]
6. Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. Rite I, Machado A, Cano J, Venero JL. J Neurochem; 2007 Jun 21; 101(6):1567-82. PubMed ID: 17437543 [Abstract] [Full Text] [Related]
7. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Fan LW, Pang Y, Lin S, Rhodes PG, Cai Z. Neuroscience; 2005 Jun 21; 133(1):159-68. PubMed ID: 15893639 [Abstract] [Full Text] [Related]
8. The intranigral injection of tissue plasminogen activator induced blood-brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat. Villarán RF, de Pablos RM, Argüelles S, Espinosa-Oliva AM, Tomás-Camardiel M, Herrera AJ, Cano J, Machado A. Neurotoxicology; 2009 May 21; 30(3):403-13. PubMed ID: 19442825 [Abstract] [Full Text] [Related]
9. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. Liu B, Jiang JW, Wilson BC, Du L, Yang SN, Wang JY, Wu GC, Cao XD, Hong JS. J Pharmacol Exp Ther; 2000 Oct 21; 295(1):125-32. PubMed ID: 10991969 [Abstract] [Full Text] [Related]
10. Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. Hernández-Romero MC, Argüelles S, Villarán RF, de Pablos RM, Delgado-Cortés MJ, Santiago M, Herrera AJ, Cano J, Machado A. J Neurochem; 2008 Apr 21; 105(2):445-59. PubMed ID: 18047562 [Abstract] [Full Text] [Related]
11. Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus. Ryu JK, McLarnon JG. Exp Neurol; 2006 Apr 21; 198(2):552-7. PubMed ID: 16480717 [Abstract] [Full Text] [Related]
12. Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development. Stolp HB, Ek CJ, Johansson PA, Dziegielewska KM, Potter AM, Habgood MD, Saunders NR. Eur J Neurosci; 2007 Dec 21; 26(12):3465-74. PubMed ID: 18088277 [Abstract] [Full Text] [Related]
13. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Ling Z, Zhu Y, Tong Cw, Snyder JA, Lipton JW, Carvey PM. Exp Neurol; 2006 Jun 21; 199(2):499-512. PubMed ID: 16504177 [Abstract] [Full Text] [Related]
14. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G. J Neurochem; 2007 Mar 21; 100(5):1375-86. PubMed ID: 17254027 [Abstract] [Full Text] [Related]
16. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH, Jenner P. Exp Neurol; 2008 Aug 21; 212(2):522-31. PubMed ID: 18571649 [Abstract] [Full Text] [Related]